✦ LIBER ✦

Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials)

✍ Scribed by Maron, Bradley A.; Waxman, Aaron B.; Opotowsky, Alexander R.; Gillies, Hunter; Blair, Christiana; Aghamohammadzadeh, Reza; Loscalzo, Joseph; Leopold, Jane A.

Book ID: 120477113
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 566 KB
Volume: 112
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2013.04.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV88 THE COST EFFECTIVENESS OF AMBRISEN

PCV88 THE COST EFFECTIVENESS OF AMBRISENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN IRELAND

✍ S Redmond; D Bozkaya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

A pilot study of the effect of spironola

A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial

✍ Jason M Elinoff, J Eduardo Rame, Paul R Forfia, Mary K Hall, Junfeng Sun… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 356 KB

Riociguat for the Treatment of Patients

Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH): Responder Analysis of Who Functional Class III Patients from the Patent-1 Study

✍ Grünig, E.; Sikirica, M.; Curram, J.; Davie, N.; Ghofrani, H.A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Combined data from two phase III trials

Combined data from two phase III trials of the NK1antagonist aprepitant plus a 5HT3antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response

✍ P. J. Hesketh; S. M. Grunberg; J. Herrstedt; R. de Wit; R. J. Gralla; A. D. Cari 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Paclitaxel plus cisplatin is as effectiv

Paclitaxel plus cisplatin is as effective as regimens containing gemcitabine in people with advanced non-small cell lung cancer: Abstracted from: Smit EF, van Meerbeeck JP, Lianes P, et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 2003;21:3909–17.

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB